Search research articles
Contact Us
Filters
Showing results (1-10 of 65) with videos related to
Page
of 7
Sort By:
Seminars in Radiation Oncology
|
March 28, 2002
The evolution and application of toxicity criteria
Andy Trotti
International Journal of Radiation Oncology, Biology, Physics
|
October 12, 2014
RTOG 9003: legacies of a landmark trial
Andy Trotti, Mitchell Machtay
The Lancet. Oncology
|
February 1, 2011
Reducing xerostomia through advanced technology
Andy Trotti, Avi Eisbruch
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 6, 2003
The need for adverse effects reporting standards in oncology clinical trials
Andy Trotti, Soren M Bentzen
International Journal of Radiation Oncology, Biology, Physics
|
October 16, 2002
Adverse effects: a Pandora's box for oncology
Andy Trotti, Lisa Judy Chin
Cancer Treatment and Research
|
December 13, 2005
Skin changes
Gloria Wood, Linda Casey, Andy Trotti
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2015
Organ Preservation for Advanced Larynx Cancer: Issues and Outcomes
Arlene A Forastiere, Randal S Weber, Andy Trotti
The New England Journal of Medicine
|
March 8, 2008
Treatment of head and neck cancer
Andy Trotti, Thomas F Pajak, John A Ridge
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 10, 2007
Patient-reported outcomes and the evolution of adverse event reporting in oncology
Andy Trotti, A Dimitrios Colevas, Ann Setser, et al.
The Journal of Oncology Management : the Official Journal of the American College of Oncology Administrators
|
May 7, 2002
Assessment of toxicity in cooperative oncology clinical trials: the long and short of it
Clement K Gwede, Darlene J Johnson, Stephanie S Daniels, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 65) with videos related to
Sort By:
Page
of 7
Seminars in Radiation Oncology
|
March 28, 2002
The evolution and application of toxicity criteria
Andy Trotti
International Journal of Radiation Oncology, Biology, Physics
|
October 12, 2014
RTOG 9003: legacies of a landmark trial
Andy Trotti, Mitchell Machtay
The Lancet. Oncology
|
February 1, 2011
Reducing xerostomia through advanced technology
Andy Trotti, Avi Eisbruch
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 6, 2003
The need for adverse effects reporting standards in oncology clinical trials
Andy Trotti, Soren M Bentzen
International Journal of Radiation Oncology, Biology, Physics
|
October 16, 2002
Adverse effects: a Pandora's box for oncology
Andy Trotti, Lisa Judy Chin
Cancer Treatment and Research
|
December 13, 2005
Skin changes
Gloria Wood, Linda Casey, Andy Trotti
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2015
Organ Preservation for Advanced Larynx Cancer: Issues and Outcomes
Arlene A Forastiere, Randal S Weber, Andy Trotti
The New England Journal of Medicine
|
March 8, 2008
Treatment of head and neck cancer
Andy Trotti, Thomas F Pajak, John A Ridge
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 10, 2007
Patient-reported outcomes and the evolution of adverse event reporting in oncology
Andy Trotti, A Dimitrios Colevas, Ann Setser, et al.
The Journal of Oncology Management : the Official Journal of the American College of Oncology Administrators
|
May 7, 2002
Assessment of toxicity in cooperative oncology clinical trials: the long and short of it
Clement K Gwede, Darlene J Johnson, Stephanie S Daniels, et al.
Page
of 7